BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 27552094)

  • 21. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wisconsin Cytology Proficiency Testing Program. Results of voluntary testing in 1994.
    Smith MA; Shalkham JE; Inhorn SL
    Acta Cytol; 1997; 41(6):1681-9. PubMed ID: 9390124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appeals in gynecologic cytology proficiency testing: review and analysis of data from the 2006 College of American Pathologists gynecologic cytology proficiency testing program.
    Crothers BA; Moriarty AT; Fatheree LA; Booth CN; Tench WD; Wilbur DC;
    Arch Pathol Lab Med; 2009 Jan; 133(1):44-8. PubMed ID: 19123735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
    Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
    Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bethesda Interobserver Reproducibility Study-2 (BIRST-2): Bethesda System 2014.
    Kurtycz DFI; Staats PN; Chute DJ; Russell D; Pavelec D; Monaco SE; Friedlander MA; Wilbur DC; Nayar R
    J Am Soc Cytopathol; 2017; 6(4):131-144. PubMed ID: 31043266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving accuracy in gynecologic cytology. Results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
    Davey DD; Nielsen ML; Frable WJ; Rosenstock W; Lowell DM; Kraemer BB
    Arch Pathol Lab Med; 1993 Dec; 117(12):1193-8. PubMed ID: 8250686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytology of spontaneous nipple discharge--is it worth it? Performance of nipple discharge preparations in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology.
    Moriarty AT; Schwartz MR; Laucirica R; Booth CN; Auger M; Thomas NE; Souers RJ
    Arch Pathol Lab Med; 2013 Aug; 137(8):1039-42. PubMed ID: 23899058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
    Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
    Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
    Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology.
    Selvaggi SM
    J Am Soc Cytopathol; 2015; 4(5):290-293. PubMed ID: 31051767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic concordance in gynecologic cytology].
    Lazcano Ponce EC; de Ruiz PA; Martínez Arias C; Murguía Riechers L
    Rev Invest Clin; 1997; 49(2):111-6. PubMed ID: 9380963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists.
    Chhieng DC; Bakdounes K; Connolly M; Gallaspy S; Roberson J; Eltoum I
    Diagn Cytopathol; 2009 May; 37(5):320-3. PubMed ID: 19191288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robustness of validation criteria in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
    Renshaw AA; Walsh MK; Blond B; Moriarty AT; Mody DR; Colgan TJ;
    Arch Pathol Lab Med; 2006 Aug; 130(8):1119-22. PubMed ID: 16879011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
    Paquette C; Mills AM; Stoler MH
    Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
    Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
    Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squamous intraepithelial lesions in cervical tissue samples of limited adequacy and insufficient for grading as low or high grade: outcome, clinico-pathological correlates, and predictive role of p16INK4a and Ki67 biomarker staining.
    Lee S; Sabourin J; Gage J; Franko A; Nation JG; Duggan MA
    J Low Genit Tract Dis; 2015 Jan; 19(1):35-45. PubMed ID: 24859844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
    Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
    Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory.
    Zheng B; Austin RM; Liang X; Li Z; Chen C; Yan S; Zhao C
    J Am Soc Cytopathol; 2015; 4(2):84-89. PubMed ID: 31051714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.